Literature DB >> 25820680

Clinical picture and risk prediction of short-term mortality in cardiogenic shock.

Veli-Pekka Harjola1, Johan Lassus, Alessandro Sionis, Lars Køber, Tuukka Tarvasmäki, Jindrich Spinar, John Parissis, Marek Banaszewski, Jose Silva-Cardoso, Valentina Carubelli, Salvatore Di Somma, Heli Tolppanen, Uwe Zeymer, Holger Thiele, Markku S Nieminen, Alexandre Mebazaa.   

Abstract

AIMS: The aim of this study was to investigate the clinical picture and outcome of cardiogenic shock and to develop a risk prediction score for short-term mortality. METHODS AND
RESULTS: The CardShock study was a multicentre, prospective, observational study conducted between 2010 and 2012. Patients with either acute coronary syndrome (ACS) or non-ACS aetiologies were enrolled within 6 h from detection of cardiogenic shock defined as severe hypotension with clinical signs of hypoperfusion and/or serum lactate >2 mmol/L despite fluid resuscitation (n = 219, mean age 67, 74% men). Data on clinical presentation, management, and biochemical variables were compared between different aetiologies of shock. Systolic blood pressure was on average 78 mmHg (standard deviation 14 mmHg) and mean arterial pressure 57 (11) mmHg. The most common cause (81%) was ACS (68% ST-elevation myocardial infarction and 8% mechanical complications); 94% underwent coronary angiography, of which 89% PCI. Main non-ACS aetiologies were severe chronic heart failure and valvular causes. In-hospital mortality was 37% (n = 80). ACS aetiology, age, previous myocardial infarction, prior coronary artery bypass, confusion, low LVEF, and blood lactate levels were independently associated with increased mortality. The CardShock risk Score including these variables and estimated glomerular filtration rate predicted in-hospital mortality well (area under the curve 0.85).
CONCLUSION: Although most commonly due to ACS, other causes account for one-fifth of cases with shock. ACS is independently associated with in-hospital mortality. The CardShock risk Score, consisting of seven common variables, easily stratifies risk of short-term mortality. It might facilitate early decision-making in intensive care or guide patient selection in clinical trials. TRIAL REGISTRATION: NCT01374867.
© 2015 The Authors. European Journal of Heart Failure © 2015 European Society of Cardiology.

Entities:  

Keywords:  Acute coronary syndromes; Acute myocardial infarction; Cardiogenic shock; Management; Prognosis; Risk score

Mesh:

Year:  2015        PMID: 25820680     DOI: 10.1002/ejhf.260

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  134 in total

Review 1.  Management of refractory cardiogenic shock.

Authors:  Alex Reyentovich; Maya H Barghash; Judith S Hochman
Journal:  Nat Rev Cardiol       Date:  2016-06-30       Impact factor: 32.419

Review 2.  Indications and practical approach to non-invasive ventilation in acute heart failure.

Authors:  Josep Masip; W Frank Peacock; Susanna Price; Louise Cullen; F Javier Martin-Sanchez; Petar Seferovic; Alan S Maisel; Oscar Miro; Gerasimos Filippatos; Christiaan Vrints; Michael Christ; Martin Cowie; Elke Platz; John McMurray; Salvatore DiSomma; Uwe Zeymer; Hector Bueno; Chris P Gale; Maddalena Lettino; Mucio Tavares; Frank Ruschitzka; Alexandre Mebazaa; Veli-Pekka Harjola; Christian Mueller
Journal:  Eur Heart J       Date:  2018-01-01       Impact factor: 29.983

3.  Clinical characteristics and prognostic factors in acute coronary syndrome patients complicated with cardiogenic shock in Japan: analysis from the Japanese Circulation Society Cardiovascular Shock Registry.

Authors:  Kazuo Sakamoto; Tetsuya Matoba; Masahiro Mohri; Yasushi Ueki; Yasuyuki Tsujita; Masao Yamasaki; Nobuhiro Tanaka; Yohei Hokama; Motoki Fukutomi; Katsutaka Hashiba; Rei Fukuhara; Satoru Suwa; Hirohide Matsuura; Eizo Tachibana; Naohiro Yonemoto; Ken Nagao
Journal:  Heart Vessels       Date:  2019-02-04       Impact factor: 2.037

4.  Predictive value of the baseline electrocardiogram ST-segment pattern in cardiogenic shock: Results from the CardShock Study.

Authors:  Tuija Javanainen; Heli Tolppanen; Johan Lassus; Markku S Nieminen; Alessandro Sionis; Jindrich Spinar; José Silva-Cardoso; Matias Greve Lindholm; Marek Banaszewski; Veli-Pekka Harjola; Raija Jurkko
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-05-30       Impact factor: 1.468

Review 5.  ECMO and Short-term Support for Cardiogenic Shock in Heart Failure.

Authors:  Mathew Jose Chakaramakkil; Cumaraswamy Sivathasan
Journal:  Curr Cardiol Rep       Date:  2018-08-16       Impact factor: 2.931

6.  First-Line Support by Intra-Aortic Balloon Pump in Non-Ischaemic Cardiogenic Shock in the Era of Modern Ventricular Assist Devices.

Authors:  Corstiaan A den Uil; Giorgia Galli; Lucia S Jewbali; Kadir Caliskan; Olivier C Manintveld; Jasper J Brugts; Nicolas M van Mieghem; Mattie J Lenzen; Eric Boersma; Alina A Constantinescu
Journal:  Cardiology       Date:  2017-05-13       Impact factor: 1.869

Review 7.  Systems of Care in Cardiogenic Shock.

Authors:  Maria M Patarroyo Aponte; Carlos Manrique; Biswajit Kar
Journal:  Methodist Debakey Cardiovasc J       Date:  2020 Jan-Mar

Review 8.  Cardiogenic Shock in Patients with Advanced Chronic Heart Failure.

Authors:  Cesar Y Guerrero-Miranda; Shelley A Hall
Journal:  Methodist Debakey Cardiovasc J       Date:  2020 Jan-Mar

Review 9.  Cardiogenic Shock in the Setting of Acute Myocardial Infarction.

Authors:  Navin K Kapur; Katherine L Thayer; Elric Zweck
Journal:  Methodist Debakey Cardiovasc J       Date:  2020 Jan-Mar

Review 10.  Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Authors:  Veli-Pekka Harjola; Wilfried Mullens; Marek Banaszewski; Johann Bauersachs; Hans-Peter Brunner-La Rocca; Ovidiu Chioncel; Sean P Collins; Wolfram Doehner; Gerasimos S Filippatos; Andreas J Flammer; Valentin Fuhrmann; Mitja Lainscak; Johan Lassus; Matthieu Legrand; Josep Masip; Christian Mueller; Zoltán Papp; John Parissis; Elke Platz; Alain Rudiger; Frank Ruschitzka; Andreas Schäfer; Petar M Seferovic; Hadi Skouri; Mehmet Birhan Yilmaz; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2017-05-30       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.